Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Cytomegalovirus Infection

Free Subscription Articles published in PLoS One Retrieve available abstracts of 97 articles: HTML format

Single Articles

January 2021
1. SEO E, Choi ES, Kim JH, Kim H, et al
   Immunologic monitoring of cytomegalovirus (CMV) enzyme-linked immune absorbent spot (ELISPOT) for controlling clinically significant CMV infection in pediatric allogeneic hematopoietic stem cell transplant recipients.
   PLoS One. 2021;16:e0246191.
   PubMed     Abstract available
   
   
   
2. KIROS M, Geteneh A, Andualem H, Alemu D, et al
   Human cytomegalovirus infection among treatment-naive HIV-1 infected patients in Ethiopia.
   PLoS One. 2021;16:e0247264.
   PubMed     Abstract available
   
   
   
3. YANG TH, Huang HM, Hsu WC, Tsao PN, et al
   The prevalence and demographic features of congenital cytomegalovirus infection in an urban area of East Asia: A population-based study.
   PLoS One. 2021;16:e0248801.
   PubMed     Abstract available
   
   
   January 2020
4. NAGEL A, Dimitrakopoulou E, Teig N, Kern P, et al
   Characterization of a universal screening approach for congenital CMV infection based on a highly-sensitive, quantitative, multiplex real-time PCR assay.
   PLoS One. 2020;15:e0227143.
   PubMed     Abstract available
   
   
   
5. WESTMAN G, Schoofs C, Ingelsson M, Jarhult JD, et al
   Torque teno virus viral load is related to age, CMV infection and HLA type but not to Alzheimer's disease.
   PLoS One. 2020;15:e0227670.
   PubMed     Abstract available
   
   
   
6. BALLEGAARD V, Pedersen KK, Braendstrup P, Kirkby N, et al
   Cytomegalovirus-specific CD8+ T-cell responses are associated with arterial blood pressure in people living with HIV.
   PLoS One. 2020;15:e0226182.
   PubMed     Abstract available
   
   
   
7. BEARDEN A, Van Winden K, Frederick T, Kono N, et al
   Low maternal vitamin D is associated with increased risk of congenital and peri/postnatal transmission of Cytomegalovirus in women with HIV.
   PLoS One. 2020;15:e0228900.
   PubMed     Abstract available
   
   
   
8. SHEN ZZ, Pan X, Miao LF, Ye HQ, et al
   Correction: Comprehensive Analysis of Human Cytomegalovirus MicroRNA Expression during Lytic and Quiescent Infection.
   PLoS One. 2020;15:e0231909.
   PubMed     Abstract available
   
   
   
9. DUVER F, Weissbrich B, Eyrich M, Wolfl M, et al
   Viral reactivations following hematopoietic stem cell transplantation in pediatric patients - A single center 11-year analysis.
   PLoS One. 2020;15:e0228451.
   PubMed     Abstract available
   
   
   
10. FAURE BARDON V, Peytavin G, Le MP, Guilleminot T, et al
    Placental transfer of Letermovir & Maribavir in the ex vivo human cotyledon perfusion model. New perspectives for in utero treatment of congenital cytomegalovirus infection.
    PLoS One. 2020;15:e0232140.
    PubMed     Abstract available
    
    
    
11. KOSHIZUKA T, Inoue N
    Activation of c-Jun by human cytomegalovirus UL42 through JNK activation.
    PLoS One. 2020;15:e0232635.
    PubMed     Abstract available
    
    
    
12. JEDLINSKA-PIJANOWSKA D, Kasztelewicz B, Czech-Kowalska J, Jaworski M, et al
    Association between single nucleotide polymorphisms (SNPs) of IL1, IL12, IL28 and TLR4 and symptoms of congenital cytomegalovirus infection.
    PLoS One. 2020;15:e0233096.
    PubMed     Abstract available
    
    
    
13. EUN K, Hong N, Jeong YW, Park MG, et al
    Transcriptional activities of human elongation factor-1alpha and cytomegalovirus promoter in transgenic dogs generated by somatic cell nuclear transfer.
    PLoS One. 2020;15:e0233784.
    PubMed     Abstract available
    
    
    
14. SIMARD J, Marschang RE, Leineweber C, Hellebuyck T, et al
    Prevalence of inclusion body disease and associated comorbidity in captive collections of boid and pythonid snakes in Belgium.
    PLoS One. 2020;15:e0229667.
    PubMed     Abstract available
    
    
    
15. LAZZAROTTO T, Chiereghin A, Piralla A, Gibertoni D, et al
    Kinetics of cytomegalovirus and Epstein-Barr virus DNA in whole blood and plasma of kidney transplant recipients: Implications on management strategies.
    PLoS One. 2020;15:e0238062.
    PubMed     Abstract available
    
    
    
16. KIM JY, Hong SY, Park WK, Kim RY, et al
    Prognostic factors of cytomegalovirus retinitis after hematopoietic stem cell transplantation.
    PLoS One. 2020;15:e0238257.
    PubMed     Abstract available
    
    
    
17. PATHIRANA J, Texeira L, Munian H, Nakwa F, et al
    Neurological and growth outcomes in South African children with congenital cytomegalovirus: A cohort study.
    PLoS One. 2020;15:e0238102.
    PubMed     Abstract available
    
    
    
18. JUNG HY, Seo MY, Jeon Y, Huh KH, et al
    Tacrolimus trough levels higher than 6 ng/mL might not be required after a year in stable kidney transplant recipients.
    PLoS One. 2020;15:e0235418.
    PubMed     Abstract available
    
    
    
19. DEMMLER-HARRISON GJ, Miller JA
    Maternal cytomegalovirus immune status and hearing loss outcomes in congenital cytomegalovirus-infected offspring.
    PLoS One. 2020;15:e0240172.
    PubMed     Abstract available
    
    
    
20. CHAMSEDDINE S, Chmaisse A, Akel I, Zein ZE, et al
    Epidemiology and clinical characteristics of viral infections in hospitalized children and adolescents with cancer in Lebanon.
    PLoS One. 2020;15:e0239258.
    PubMed     Abstract available
    
    
    January 2019
21. GRIFFITHS GO, Cowan RA, Grigor KM, Uscinska BM, et al
    BA08: An open-label, single-arm, non-randomised, phase 2 trial of cisplatin, methotrexate and vinblastine (CMV) for pure squamous cell cancer of the urinary tract.
    PLoS One. 2019;14:e0210785.
    PubMed     Abstract available
    
    
    
22. HANSEN SG, Womack J, Scholz I, Renner A, et al
    Cytomegalovirus vectors expressing Plasmodium knowlesi antigens induce immune responses that delay parasitemia upon sporozoite challenge.
    PLoS One. 2019;14:e0210252.
    PubMed     Abstract available
    
    
    
23. LUMLEY S, Green C, Rafferty H, Smith C, et al
    Cytomegalovirus viral load parameters associated with earlier initiation of pre-emptive therapy after solid organ transplantation.
    PLoS One. 2019;14:e0210420.
    PubMed     Abstract available
    
    
    
24. VARANASI PR, Ogonek J, Luther S, Dammann E, et al
    Cytomegalovirus-specific CD8+ T-cells are associated with a reduced incidence of early relapse after allogeneic stem cell transplantation.
    PLoS One. 2019;14:e0213739.
    PubMed     Abstract available
    
    
    
25. CHOI JA, Kim JE, Ju HH, Lee J, et al
    The effects of losartan on cytomegalovirus infection in human trabecular meshwork cells.
    PLoS One. 2019;14:e0218471.
    PubMed     Abstract available
    
    
    
26. MORISHITA M, Sada KE, Matsumoto Y, Hayashi K, et al
    Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
    PLoS One. 2019;14:e0218705.
    PubMed     Abstract available
    
    
    
27. LOPEZ-ALADID R, Guiu A, Mosquera MM, Lopez-Medrano F, et al
    Improvement in detecting cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance using next generation sequencing.
    PLoS One. 2019;14:e0219701.
    PubMed     Abstract available
    
    
    
28. CHOI JA, Kim JE, Ju HH, Lee J, et al
    Correction: The effects of losartan on cytomegalovirus infection in human trabecular meshwork cells.
    PLoS One. 2019;14:e0221693.
    PubMed     Abstract available
    
    
    
29. CUI J, Yan W, Xie H, Xu S, et al
    Cytomegalovirus antigenemia in patients with autoimmune and non-autoimmune diseases in Beijing: A 10-year single hospital experience.
    PLoS One. 2019;14:e0221793.
    PubMed     Abstract available
    
    
    
30. TASTAD KJ, Schleiss MR, Lammert SM, Basta NE, et al
    Awareness of congenital cytomegalovirus and acceptance of maternal and newborn screening.
    PLoS One. 2019;14:e0221725.
    PubMed     Abstract available
    
    
    
31. BERG C, Friis MB, Rosenkilde MM, Benfield T, et al
    Development of highly efficient protocols for extraction and amplification of cytomegalovirus DNA from dried blood spots for detection and genotyping of polymorphic immunomodulatory genes.
    PLoS One. 2019;14:e0222053.
    PubMed     Abstract available
    
    
    
32. DWORZANSKI J, Drop B, Kliszczewska E, Strycharz-Dudziak M, et al
    Prevalence of Epstein-Barr virus, human papillomavirus, cytomegalovirus and herpes simplex virus type 1 in patients with diabetes mellitus type 2 in south-eastern Poland.
    PLoS One. 2019;14:e0222607.
    PubMed     Abstract available
    
    
    
33. AGNARSDOTTIR M, Popova S, Alafuzoff I
    Expression of CMV protein pp65 in cutaneous malignant melanoma.
    PLoS One. 2019;14:e0223854.
    PubMed     Abstract available
    
    
    
34. GUO X, Liu Y, Kim JL, Kim EY, et al
    Effect of cyclical intermittent hypoxia on Ad5CMVCre induced solitary lung cancer progression and spontaneous metastases in the KrasG12D+; p53fl/fl; myristolated p110fl/fl ROSA-gfp mouse.
    PLoS One. 2019;14:e0212930.
    PubMed     Abstract available
    
    
    
35. RAMESH A, Nakielny S, Hsu J, Kyohere M, et al
    Metagenomic next-generation sequencing of samples from pediatric febrile illness in Tororo, Uganda.
    PLoS One. 2019;14:e0218318.
    PubMed     Abstract available
    
    
    
36. COTTON MF, Rabie H, Nemes E, Mujuru H, et al
    A prospective study of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected children from high prevalence countries.
    PLoS One. 2019;14:e0211155.
    PubMed     Abstract available
    
    
    
37. GHOSH S, Shetty RS, Pattanshetty SM, Mallya SD, et al
    Human papilloma and other DNA virus infections of the cervix: A population based comparative study among tribal and general population in India.
    PLoS One. 2019;14:e0219173.
    PubMed     Abstract available
    
    
    
38. FERNANDES-CHARPIOT IMM, Estofolete CF, Caldas HC, de Souza GR, et al
    Clinical and laboratorial profiles of dengue virus infection in kidney transplant recipients: Report of a single center.
    PLoS One. 2019;14:e0219117.
    PubMed     Abstract available
    
    
    
39. CHANDE S, Ho B, Fetene J, Bergwitz C, et al
    Transgenic mouse model for conditional expression of influenza hemagglutinin-tagged human SLC20A1/PIT1.
    PLoS One. 2019;14:e0223052.
    PubMed     Abstract available
    
    
    
40. FAIST B, Schlott F, Stemberger C, Dennehy KM, et al
    Targeted in-vitro-stimulation reveals highly proliferative multi-virus-specific human central memory T cells as candidates for prophylactic T cell therapy.
    PLoS One. 2019;14:e0223258.
    PubMed     Abstract available
    
    
    
41. DEAN NJ, Pastras C, Brown D, Camp A, et al
    Are viral-infections associated with Meniere's Disease? A systematic review and meta-analysis of molecular-markers of viral-infection in case-controlled observational studies of MD.
    PLoS One. 2019;14:e0225650.
    PubMed     Abstract available
    
    
    January 2018
42. WADUTHANTRI S, Zhou L, Chee SP
    Intra-cameral level of ganciclovir gel, 0.15% following topical application for cytomegalovirus anterior segment infection: A pilot study.
    PLoS One. 2018;13:e0191850.
    PubMed     Abstract available
    
    
    
43. KOLDEHOFF M, Lindemann M, Ross SR, Elmaagacli AH, et al
    Cytomegalovirus induces HLA-class-II-restricted alloreactivity in an acute myeloid leukemia cell line.
    PLoS One. 2018;13:e0191482.
    PubMed     Abstract available
    
    
    
44. STOCKDALE L, Nash S, Nalwoga A, Painter H, et al
    Human cytomegalovirus epidemiology and relationship to tuberculosis and cardiovascular disease risk factors in a rural Ugandan cohort.
    PLoS One. 2018;13:e0192086.
    PubMed     Abstract available
    
    
    
45. SCHLOTT F, Steubl D, Ameres S, Moosmann A, et al
    Characterization and clinical enrichment of HLA-C*07:02-restricted Cytomegalovirus-specific CD8+ T cells.
    PLoS One. 2018;13:e0193554.
    PubMed     Abstract available
    
    
    
46. DRABORG AH, Rasmussen NS, Larsen JL, Jorgensen CS, et al
    Immune responses to an early lytic cytomegalovirus antigen in systemic lupus erythematosus patients: T-cell responses, cytokine secretions and antibody status.
    PLoS One. 2018;13:e0193244.
    PubMed     Abstract available
    
    
    
47. MADRID L, Varo R, Maculuve S, Nhampossa T, et al
    Congenital cytomegalovirus, parvovirus and enterovirus infection in Mozambican newborns at birth: A cross-sectional survey.
    PLoS One. 2018;13:e0194186.
    PubMed     Abstract available
    
    
    
48. CHANOUZAS D, Small A, Borrows R, Ball S, et al
    Assessment of the T-SPOT.CMV interferon-gamma release assay in renal transplant recipients: A single center cohort study.
    PLoS One. 2018;13:e0193968.
    PubMed     Abstract available
    
    
    
49. GERGEN J, Coulon F, Creneguy A, Elain-Duret N, et al
    Multiplex CRISPR/Cas9 system impairs HCMV replication by excising an essential viral gene.
    PLoS One. 2018;13:e0192602.
    PubMed     Abstract available
    
    
    
50. IGLESIAS-ESCUDERO M, Moro-Garcia MA, Marcos-Fernandez R, Garcia-Torre A, et al
    Levels of anti-CMV antibodies are modulated by the frequency and intensity of virus reactivations in kidney transplant patients.
    PLoS One. 2018;13:e0194789.
    PubMed     Abstract available
    
    
    
51. GIMENO BRIAS S, Marsden M, Forbester J, Clement M, et al
    Interferon lambda is required for interferon gamma-expressing NK cell responses but does not afford antiviral protection during acute and persistent murine cytomegalovirus infection.
    PLoS One. 2018;13:e0197596.
    PubMed     Abstract available
    
    
    
52. ROVITO R, Warnatz HJ, Kielbasa SM, Mei H, et al
    Impact of congenital cytomegalovirus infection on transcriptomes from archived dried blood spots in relation to long-term clinical outcome.
    PLoS One. 2018;13:e0200652.
    PubMed     Abstract available
    
    
    
53. STRANG BL, Asquith CRM, Moshrif HF, Ho CM, et al
    Identification of lead anti-human cytomegalovirus compounds targeting MAP4K4 via machine learning analysis of kinase inhibitor screening data.
    PLoS One. 2018;13:e0201321.
    PubMed     Abstract available
    
    
    
54. WEHRENS EJ, Wong KA, Gupta A, Khan A, et al
    IL-27 regulates the number, function and cytotoxic program of antiviral CD4 T cells and promotes cytomegalovirus persistence.
    PLoS One. 2018;13:e0201249.
    PubMed     Abstract available
    
    
    
55. LACHMANN R, Loenenbach A, Waterboer T, Brenner N, et al
    Cytomegalovirus (CMV) seroprevalence in the adult population of Germany.
    PLoS One. 2018;13:e0200267.
    PubMed     Abstract available
    
    
    
56. ANNIBALI O, Piccioni L, Tomarchio V, Circhetta E, et al
    Impact of IFN lambda 3/4 single nucleotide polymorphisms on the cytomegalovirus reactivation in autologous stem cell transplant patients.
    PLoS One. 2018;13:e0200221.
    PubMed     Abstract available
    
    
    
57. NISBET AI, Omuse G, Revathi G, Adam RD, et al
    Seroprevalence data at a private teaching hospital in Kenya: An examination of Toxoplasma gondii, cytomegalovirus, rubella, hepatitis A, and Entamoeba histolytica.
    PLoS One. 2018;13:e0204867.
    PubMed     Abstract available
    
    
    
58. KAUR A, Itell HL, Ehlinger EP, Varner V, et al
    Natural history of postnatal rhesus cytomegalovirus shedding by dams and acquisition by infant rhesus monkeys.
    PLoS One. 2018;13:e0206330.
    PubMed     Abstract available
    
    
    
59. KAMTCHUM-TATUENE J, Al-Bayati Z, Mwandumba HC, Solomon T, et al
    Serum concentration of anti-Cytomegalovirus IgG and ischaemic stroke in patients with advanced HIV infection in Malawi.
    PLoS One. 2018;13:e0208040.
    PubMed     Abstract available
    
    
    
60. WIDMAN DG, Gornisiewicz S, Shacham S, Tamir S, et al
    In vitro toxicity and efficacy of verdinexor, an exportin 1 inhibitor, on opportunistic viruses affecting immunocompromised individuals.
    PLoS One. 2018;13:e0200043.
    PubMed     Abstract available
    
    
    January 2017
61. STUDZINSKA M, Jablonska A, Wisniewska-Ligier M, Nowakowska D, et al
    Association of TLR3 L412F Polymorphism with Cytomegalovirus Infection in Children.
    PLoS One. 2017;12:e0169420.
    PubMed     Abstract available
    
    
    
62. SCHLOTT F, Steubl D, Hoffmann D, Matevossian E, et al
    Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients Is Associated with Protracted Cold Ischemic Time of Seropositive Donor Organs.
    PLoS One. 2017;12:e0171035.
    PubMed     Abstract available
    
    
    
63. ALSTON CI, Dix RD
    Murine cytomegalovirus infection of mouse macrophages stimulates early expression of suppressor of cytokine signaling (SOCS)1 and SOCS3.
    PLoS One. 2017;12:e0171812.
    PubMed     Abstract available
    
    
    
64. BOECK JM, Spencer JV
    Effect of human cytomegalovirus (HCMV) US27 on CXCR4 receptor internalization measured by fluorogen-activating protein (FAP) biosensors.
    PLoS One. 2017;12:e0172042.
    PubMed     Abstract available
    
    
    
65. GUO G, Zhang L, Ye S, Hu Y, et al
    Polymorphisms and features of cytomegalovirus UL144 and UL146 in congenitally infected neonates with hepatic involvement.
    PLoS One. 2017;12:e0171959.
    PubMed     Abstract available
    
    
    
66. OTGONJARGALA B, Becker K, Batbaatar G, Tsogtsaikhan S, et al
    Effect of Mycoplasma hominis and cytomegalovirus infection on pregnancy outcome: A prospective study of 200 Mongolian women and their newborns.
    PLoS One. 2017;12:e0173283.
    PubMed     Abstract available
    
    
    
67. LE-TRILLING VT, Trilling M
    Mouse newborn cells allow highly productive mouse cytomegalovirus replication, constituting a novel convenient primary cell culture system.
    PLoS One. 2017;12:e0174695.
    PubMed     Abstract available
    
    
    
68. GAN X, Wang H, Yu Y, Yi W, et al
    Epigenetically repressing human cytomegalovirus lytic infection and reactivation from latency in THP-1 model by targeting H3K9 and H3K27 histone demethylases.
    PLoS One. 2017;12:e0175390.
    PubMed     Abstract available
    
    
    
69. JIANG XJ, Zhang J, Xiong Y, Jahn G, et al
    Human cytomegalovirus glycoprotein polymorphisms and increasing viral load in AIDS patients.
    PLoS One. 2017;12:e0176160.
    PubMed     Abstract available
    
    
    
70. YANG CF, Ho HL, Lin SC, Hsu CY, et al
    Detection of human cytomegalovirus in glioblastoma among Taiwanese subjects.
    PLoS One. 2017;12:e0179366.
    PubMed     Abstract available
    
    
    
71. TOVAR-SALAZAR A, Weinberg A
    Cytomegalovirus infection in HIV-infected and uninfected individuals is characterized by circulating regulatory T cells of unconstrained antigenic specificity.
    PLoS One. 2017;12:e0180691.
    PubMed     Abstract available
    
    
    
72. THOMASINI RL, Pereira DS, Pereira FSM, Mateo EC, et al
    Aged-associated cytomegalovirus and Epstein-Barr virus reactivation and cytomegalovirus relationship with the frailty syndrome in older women.
    PLoS One. 2017;12:e0180841.
    PubMed     Abstract available
    
    
    
73. LEE KY, Yoo BW, Ahn SS, Bae WH, et al
    Predictors of mortality in autoimmune disease patients with concurrent cytomegalovirus infections detected by quantitative real-time PCR.
    PLoS One. 2017;12:e0181590.
    PubMed     Abstract available
    
    
    
74. HALL CE, Koparde VN, Jameson-Lee M, Elnasseh AG, et al
    Sequence homology between HLA-bound cytomegalovirus and human peptides: A potential trigger for alloreactivity.
    PLoS One. 2017;12:e0178763.
    PubMed     Abstract available
    
    
    
75. TOMINO A, Tsuda M, Aoki R, Kajita Y, et al
    Increased PD-1 Expression and Altered T Cell Repertoire Diversity Predict Mortality in Patients with Septic Shock: A Preliminary Study.
    PLoS One. 2017;12:e0169653.
    PubMed     Abstract available
    
    
    
76. CHIUPPESI F, Wussow F, Scharf L, Contreras H, et al
    Comparison of homologous and heterologous prime-boost vaccine approaches using Modified Vaccinia Ankara and soluble protein to induce neutralizing antibodies by the human cytomegalovirus pentamer complex in mice.
    PLoS One. 2017;12:e0183377.
    PubMed     Abstract available
    
    
    
77. BOOIMAN T, Wit FW, Girigorie AF, Maurer I, et al
    Terminal differentiation of T cells is strongly associated with CMV infection and increased in HIV-positive individuals on ART and lifestyle matched controls.
    PLoS One. 2017;12:e0183357.
    PubMed     Abstract available
    
    
    
78. MAIER AK, Jung R, Villinger C, Schubert A, et al
    A Luciferase Gene Driven by an Alphaherpesviral Promoter Also Responds to Immediate Early Antigens of the Betaherpesvirus HCMV, Allowing Comparative Analyses of Different Human Herpesviruses in One Reporter Cell Line.
    PLoS One. 2017;12:e0169580.
    PubMed     Abstract available
    
    
    
79. LI Z, Tang Y, Tang N, Feng Q, et al
    High anti-human cytomegalovirus antibody levels are associated with the progression of essential hypertension and target organ damage in Han Chinese population.
    PLoS One. 2017;12:e0181440.
    PubMed     Abstract available
    
    
    
80. OKAHARA K, Nagata N, Shimada T, Joya A, et al
    Colonic cytomegalovirus detection by mucosal PCR and antiviral therapy in ulcerative colitis.
    PLoS One. 2017;12:e0183951.
    PubMed     Abstract available
    
    
    
81. PICAT MQ, Pellegrin I, Bitard J, Wittkop L, et al
    Integrative Analysis of Immunological Data to Explore Chronic Immune T-Cell Activation in Successfully Treated HIV Patients.
    PLoS One. 2017;12:e0169164.
    PubMed     Abstract available
    
    
    
82. GOMEZ-MORA E, Massanella M, Garcia E, Giles D, et al
    Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery.
    PLoS One. 2017;12:e0184433.
    PubMed     Abstract available
    
    
    
83. GRIFFITHS PD, Rothwell E, Raza M, Wilmore S, et al
    Correction: Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy.
    PLoS One. 2017;12:e0185298.
    PubMed     Abstract available
    
    
    
84. MULDOON KM, Armstrong-Heimsoth A, Thomas J
    Knowledge of congenital cytomegalovirus (cCMV) among physical and occupational therapists in the United States.
    PLoS One. 2017;12:e0185635.
    PubMed     Abstract available
    
    
    
85. EBADAT S, Ahmadi S, Ahmadi M, Nematpour F, et al
    Evaluating the efficiency of CHEF and CMV promoter with IRES and Furin/2A linker sequences for monoclonal antibody expression in CHO cells.
    PLoS One. 2017;12:e0185967.
    PubMed     Abstract available
    
    
    
86. SUN X, Chen W, He L, Sheng J, et al
    Inhibition of human cytomegalovirus immediate early gene expression and growth by a novel RNase P ribozyme variant.
    PLoS One. 2017;12:e0186791.
    PubMed     Abstract available
    
    
    
87. VISWANATHAN K, Verweij MC, John N, Malouli D, et al
    Quantitative membrane proteomics reveals a role for tetraspanin enriched microdomains during entry of human cytomegalovirus.
    PLoS One. 2017;12:e0187899.
    PubMed     Abstract available
    
    
    
88. MELE F, Fornara C, Jarrossay D, Furione M, et al
    Phenotype and specificity of T cells in primary human cytomegalovirus infection during pregnancy: IL-7Rpos long-term memory phenotype is associated with protection from vertical transmission.
    PLoS One. 2017;12:e0187731.
    PubMed     Abstract available
    
    
    
89. LEE H, Park KH, Ryu JH, Choi AR, et al
    Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients.
    PLoS One. 2017;12:e0189488.
    PubMed     Abstract available
    
    
    
90. MALIK A, Adland E, Laker L, Kloverpris H, et al
    Immunodominant cytomegalovirus-specific CD8+ T-cell responses in sub-Saharan African populations.
    PLoS One. 2017;12:e0189612.
    PubMed     Abstract available
    
    
    
91. ELDAR-YEDIDIA Y, Hillel M, Cohen A, Bar-Meir M, et al
    Association of toll-like receptors polymorphism and intrauterine transmission of cytomegalovirus.
    PLoS One. 2017;12:e0189921.
    PubMed     Abstract available
    
    
    January 2016
92. GRIFFITHS PD, Rothwell E, Raza M, Wilmore S, et al
    Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy.
    PLoS One. 2016;11:e0163722.
    PubMed     Abstract available
    
    
    
93. DAVIS-POYNTER N, Yunis J, Farrell HE
    The Cytoplasmic C-Tail of the Mouse Cytomegalovirus 7 Transmembrane Receptor Homologue, M78, Regulates Endocytosis of the Receptor and Modulates Virus Replication in Different Cell Types.
    PLoS One. 2016;11:e0165066.
    PubMed     Abstract available
    
    
    
94. LIU Y, Chen AS, Kamphaengkham S, Leenasirimakul P, et al
    Diagnostic Utility of Ocular Symptoms and Vision for Cytomegalovirus Retinitis.
    PLoS One. 2016;11:e0165564.
    PubMed     Abstract available
    
    
    
95. POIZOT-MARTIN I, Allavena C, Duvivier C, Cano CE, et al
    CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART.
    PLoS One. 2016;11:e0165774.
    PubMed     Abstract available
    
    
    
96. TRGOVCICH J, Kincaid M, Thomas A, Griessl M, et al
    Cytomegalovirus Reinfections Stimulate CD8 T-Memory Inflation.
    PLoS One. 2016;11:e0167097.
    PubMed     Abstract available
    
    
    
97. REMIS RS, Liu J, Loutfy MR, Tharao W, et al
    Prevalence of Sexually Transmitted Viral and Bacterial Infections in HIV-Positive and HIV-Negative Men Who Have Sex with Men in Toronto.
    PLoS One. 2016;11:e0158090.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: